Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Clinical Trial of SaiLuoTong Capsule for Vascular Dementia：A 26-week, Multicentre, Randomized, Double -Blind, Placebo-controlled Trial With a 26-week Open-label Extension

NCT01978730 is registered in ClinicalTrials.gov with Shineway Pharmaceutical Co.,Ltd as lead sponsor.

NCT NCT01978730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01978730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Clinical Trial of SaiLuoTong Capsule for Vascular Dementia：A 26-week, Multicentre, Randomized, Double -Blind, Placebo-controlled Trial With a 26-week Open-label Extension
Lead sponsor
Shineway Pharmaceutical Co.,Ltd
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2011
Completion date
July 31, 2014
Enrollment
372 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

vascular dementia